Abbvie Contract MFG

Developing a new drug is a multifaceted venture requiring many decisions and evaluations before a commercial launch. Smaller pharmaceutical companies and biotech are increasingly deciding to outsource all or most of their drug production efforts all through the production stage. Due to the high cost of facility build-out, staffing, validation, and support required to develop one product and the low rate of success of drug commercialization, the investment community does not care for the erection of production facilities to manufacture and fill a specialty medicine until profitable acceptance is impending. AbbVie Contract Manufacturing is a leading manufacturer of Active Pharmaceutical Ingredients. We offer the best custom active pharmaceutical ingredient services based on over seventy years of manufacturing success. Tips to Finding the Best CMO Here are five things to look out for when hiring the best CMO: 1. Ensure compliance and quality standards For your reputation and safety, the...

The production of a new drug is a challenging responsibility and needs many decisions and evaluations before a commercial launch. Some small pharmaceutical companies and biotech are choosing to outsource all or most of their drug production efforts throughout the manufacturing phase with a Contract Manufacturing Organization. Picking the best Contract Manufacturer is vital in pharmaceutical manufacturing to ensure the success of product and overall success in the performance of your company. Choosing the very best is a crucial decision that puts your brand's reputation, supply chain, and patient safety in the hands of a partner. For the best beneficial relationship and peace of mind, we have highlighted essential points to consider when choosing the best Contract Manufacturing Organization for your pharmaceutical product. AbbVie Contract Manufacturing is a leading producer of custom active pharmaceutical ingredient . Four Factors to Consider when Choosing the Best CMO: Here are cru...

Sterile fill finish processes are the final stage before a product is packaged, shipped, and given to patients. The primary goal during aseptic processing is to prevent the last product from getting pyrogens, particulates, or microbes. Many aspects of fill finish processes, like environmental monitoring, cleaning, facility design, and supplier quality management, are part of the risk and quality control process. Reliable fill-finish manufacturing organizations must overcome the following challenges to provide high-quality, safe products efficiently. Kindly scroll down and continue reading to learn more about this. Three Challenges in Aseptic Processing Below are some challenges in aseptic process: 1. Assuring Accurate Filling Mistakes in dispensing are always a risk and must be addressed. Expensive systems have inline process controls that track the product fill weight within each container. Although inline weight controls keep the final fill within acceptance principles, it isn’t res...

The terms “sterile” and “aseptic” are commonly used interchangeably. They both have a similar objective – reducing and/or eliminating potentially hazardous microorganisms. However, the differences are critical in pharmaceutical and cleanroom environments. Although they are both commonly used to control contamination, they are, in fact, diverse concepts. Sterile vs. Aseptic Any cleanroom employee must understand the major differences between sterile and aseptic. The industrial description of each is as follows: Sterile A sterile product is a product that is free of microscopic organisms. Sterile means the total absence of viruses, bacteria, and fungi, as well as spores. It does not differentiate between exact pathogens. A sterilization method focuses on disinfecting an environment of all harmful living microorganisms. Aseptic An environment, project, surface, or object has been treated such that it is free of infection and contamination. Viruses, bacteria, or other dangerous living org...

Hot Melt Extrusion services have advanced as an exceptional processing technology in producing molecular dispersions API into various lipid and polymer matrices. And this has led to targeted, extended, modified, and time-regulated drug delivery. Today, Hot Melt Extrusion allows us to use compounds to mask the bitter taste of active drugs. Since the industrial application of the extrusion process in the 1930s, propriety HME has gotten massive attention from the academia and pharmaceutical industry for a variety of applications for various applications for pharmaceutical dosage forms like films, capsules, tablets, and implants for drug delivery through transmucosal, transdermal, and oral routes. As a result, Hot Melt Extrusion services are a suitable alternative to other commonly used processes, such as spray drying and roll spinning at AbbVie Contract Manufacturing. In addition, we offer the best proprietary HME services in both Europe and the US. We are a leading company with over thr...

Pharmaceutical companies are using twin-screw and conical extruders to blend drug molecules with bioactive polymers in cases where the ingredients are unstable or aren’t correctly soluble during processing. Extruders are also beneficial in preparing sustained release dosages and enteric dosages, creating forms like films, and in taste-masking. HME Process HME is the processing of polymeric materials that are above their glass transition temperature. This is done in order to effect molecular level blending of thermoplastic binders and active compounds and polymers. Hot Melt Extrusions are used in various industries. It is a combination of mechanical energy and melting to improve continuous processing for reproducible analysis of online monitoring, dust reductions, and materials. In pharmaceutical production, Active Pharmaceutical Ingredients is dispersed using hot melt extrusion in a medium at the molecular stage, thereby forming solid solutions. This allows drug delivery systems for s...

Highly potent drugs denote an increasing proportion of drugs. This includes therapies in development and those that are commercially available. As older products get to patent expiry, general-drug companies are equally moving into this area, creating a continuous demand for capacity and capability to produce highly potent active pharmaceutical ingredients, especially for contract manufacturing organizations. This blog talks about risk determination in potent drug contract manufacturing. Kindly scroll down and continue reading to learn more.   Risk Determination When determining risk, the starting point is the Occupational Exposure Limits (OELs) and other safety-related properties of the molecule determined as part of the drug manufacturing process. Once a trial drug reaches the large-scale production stage, extensive safety data must have been gathered, including results from early-stage clinical trials, preclinical toxicology assessment, and animal studies. These data on potentia...

New drug compounds, especially those for the proposed use in oncology, have become more selective in their interaction with biological targets, with pharmacological activity usually attained with small amounts of the drug. The production of highly potent drug substances alongside their products needs special attention and care to guarantee the safety of those who manage the materials. Furthermore, as products having highly potent drugs usually contain minute quantities of the drug per unit dose, it is crucial that during the processing stage, excellent uniformity of dose across an entire batch is attained. Safe Management of Highly Potent Materials For the safe management of highly potent materials, production practices have moved away from dependence on safety equipment alone. Modern practices focus on suppression at source, with the use of isolator technologies to prevent the exposure of operators to such compounds all through processing. So given a new drug unit, how do we classify ...